急诊科患者围插管期不良事件与临床结局:BARCO研究
BARCO研究为巴西18家急诊科的前瞻性队列,纳入2846例成人急诊插管患者,排除择期插管和心脏骤停患者。围插管期重大不良事件定义为插管开始后30分钟内发生严重低氧血症、新发血流动力学不稳定或心脏骤停,发生率为32.3%,以新发血流动力学不稳定最常见(20.0%)。发生重大不良事件者28天死亡率显著更高(57.6% vs 39.2%;aHR 1.43,95%CI 1.26-1.62;p<0.001),首次插管成功与重大不良事件风险降低相关(aOR 0.52;95%CI 0.41-0.65;p<0.001)。
要点
- 2846例急诊插管中919例(32.3%)发生围插管期重大不良事件,新发血流动力学不稳定占20.0%、严重低氧血症占12.5%、心脏骤停占3.5%。
- 发生任何重大不良事件者28天死亡率57.6% vs 未发生者39.2%(aHR 1.43,95%CI 1.26-1.62;p<0.001)。
- 首次插管成功与重大不良事件风险降低相关(aOR 0.52;95%CI 0.41-0.65;p<0.001)。
- 总体28天死亡率为45.1%,敏感性分析结果与主分析一致。
适用人群与场景
- 巴西18家急诊科中接受急诊气管插管的成人(≥18岁)患者。
- 排除择期插管或心脏骤停插管的患者。
诊断标准与关键阈值
- 围插管期重大不良事件定义:插管开始后30分钟内发生严重低氧血症、新发血流动力学不稳定或心脏骤停。
红旗征与不能漏的情况
- 插管开始后30分钟内出现严重低氧血症、新发血流动力学不稳定或心脏骤停,均属围插管期重大不良事件,与28天死亡率升高相关(57.6% vs 39.2%;aHR 1.43,95%CI 1.26-1.62;p<0.001)。
研究设计与关键结果
- 研究类型:前瞻性队列研究,纳入巴西18家急诊科,时间2022年3月至2024年4月,共2846例成人急诊插管患者。
- 主要终点:28天死亡率总体为45.1%;发生任何围插管期重大不良事件者28天死亡率57.6% vs 未发生者39.2%(aHR 1.43,95%CI 1.26-1.62;p<0.001),敏感性分析证实该结果。
- 围插管期重大不良事件发生率32.3%(919/2846),其中新发血流动力学不稳定20.0%、严重低氧血症12.5%、心脏骤停3.5%。
- 首次插管成功与重大不良事件风险降低相关(aOR 0.52;95%CI 0.41-0.65;p<0.001)。
证据类型、等级与局限
- 证据类型:前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,结果强调优化插管策略以减少并发症、可能改善危重患者结局的重要性。
- 首次插管成功与围插管期重大不良事件风险降低相关(aOR 0.52;95%CI 0.41-0.65;p<0.001)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Emergency tracheal intubation in critically ill patients carries a high risk of complications, and practices vary substantially across different settings. Identifying risk factors and understanding how peri-intubation adverse events affect patient outcomes may guide standardization of care and improve survival.
METHODS: This prospective cohort study involved 18 emergency departments in Brazil (March 2022-April 2024). We included adults (≥ 18 years) undergoing emergency intubation and excluded patients intubated electively or for cardiac arrest. We defined major peri-intubation adverse events as severe hypoxemia, new hemodynamic instability, or cardiac arrest occurring within 30 min of initiating intubation. The primary outcome was 28-day mortality. Multivariable regression analyses assessed associations between adverse events and mortality, controlling for potential confounders.
RESULTS: Among 2846 patients, major adverse events occurred in 919 (32.3%) intubations, most frequently new hemodynamic instability (20.0%), followed by severe hypoxemia (12.5%) and cardiac arrest (3.5%). The overall 28-day mortality was 45.1%. Patients experiencing any major adverse event had a significantly higher 28-day mortality (57.6 vs 39.2%; aHR 1.43, 95% CI 1.26-1.62; p < 0.001). Sensitivity analyses confirmed these findings. Successful first-attempt intubation was associated with a reduced likelihood of major adverse events (aOR 0.52; 95% CI 0.41-0.65; p < 0.001).
CONCLUSION: One in three patients undergoing emergency intubation experienced a major peri-intubation adverse event, which was associated with higher 28-day mortality. These results underscore the importance of optimizing intubation strategies to reduce complications and potentially improve patient outcomes in critically ill patients.
参考来源
- Maia IWA, Besen BAMP, Silva LOJE, et al. Peri-intubation adverse events and clinical outcomes in emergency department patients: the BARCO study. Crit Care. 2025. PMID: 40247381. doi:10.1186/s13054-025-05392-w
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。